Patent for rapid gene discovery technology:
This article was originally published in Clinica
Executive Summary
Myriad Genetics has been granted a US patent covering a technology to speed up the discovery of disease-related genes. The method, called "island hopping", is a way of increasing the rate of sequencing large pieces of DNA by automatically selecting single bands, or islands, of DNA. The technology is used by Salt Lake City-based Myriad to highlight genes and proteins with diagnostic and therapeutic potential through its ProNet protein discovery technology. The company licenses the ProNet technology out to pharmaceuticals companies on a non-exclusive basis.
You may also be interested in...
Moderna Ready To File Vaccine After Second Impressive Read-Out
Second read-out maintains 94% level of efficacy, with a very early signal that it could outperform Pfizer’s rival mRNA candidate in preventing severe cases.
Coronavirus Notebook: UK On Cusp Of First Vaccine Approval, Moderna To File mRNA-1273 in US & EU
Russia says it will make the first deliveries of its $10-per-dose Sputnik V vaccine in January, while international regulators say vaccine trials should continue for as long as possible to generate longer-term evidence on their benefits and risks. A UK research body has stressed that drugs repurposed for COVID-19 also need to undergo thorough safety and efficacy testing as reports suggest the UK regulator could approve a vaccine within days.
Edgewell Finds COVID Bright Side: Wet Ones On Way To Becoming ‘Little Mega-Brand’
Skin hygiene is one of several categories where Edgewell Personal Care has a “right to win" after 18 months of renovations, according to the company’s 20 November Investor Day presentation. The firm has doubled its production capacity and has plans for a “full suite” of product innovation to build on Wet Ones’ 60% growth in fiscal 2020.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: